Comment on “Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma”

類似資料

• Response to the comment on “Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma” by Bielamowicz et al
  著者:: Joseph, Sujith K, 等
  出版事項: (2018)
• Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
  著者:: Bielamowicz, Kevin, 等
  出版事項: (2018)
• Steering CAR T cells to distinguish friend from foe
  著者:: Caruso, Hillary G., 等
  出版事項: (2018)
• IMMU-17. REDUCING THE EX VIVO MANUFACTURING TIME OF EGFRVIII-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS IMPROVES PHENOTYPE AND DEMONSTRATES POTENT ANTI-GLIOMA FUNCTION IN VIVO
  著者:: Tanaka, Ryuma, 等
  出版事項: (2017)
• Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
  著者:: Martínez Bedoya, Darel, 等
  出版事項: (2021)